Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204.SZ) SHZ
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 13.28B |
| Enterprise Value | 13.24B |
| P/E Ratio | -110.13 |
| PEG Ratio | -4.57 |
| Price/Sales Ratio | 49.43 |
| Price/Book Ratio | 12.1 |
| Enterprise/Revenue | 49.56 |
| Enterprise/EBITDA | -145.44 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -0.48 |
| Operating Margin | -0.49 |
AD
Management Effectiveness
| Return On Assets | -0.07 |
| Return On Equity | -0.11 |
Income Statement
| Revenue | 220.23M |
| Revenue/Share | 0.39 |
| Gross Profit | 170.15M |
| EBITDA | -55.69M |
| Net Income | -77.76M |
| Diluted EPS | -0.16 |
Balance Sheet
| Total Cash | 126.16M |
| Total Cash/Share | 0.26 |
| Total Debt | 150.57M |
| Total Debt/Equity | 0.19 |
| Current Ratio | 1.73 |
| Book Value Per Share | 1.66 |
Price History
| 52-Week Change | -39.35 |
| 52-Week High | 42.65 |
| 52-Week Low | 18.98 |
| Moving Average 50 Days | 21.94 |
| Moving Average 200 Days | 25.27 |
Statistics
| Average Volume | 31.18M |
| Shares Outstanding | 453.55M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0 |
| Last Split Factor | 1399:1000 |
| Last Split Date | May 05, 2016 |
AD
